The Latest Breaking News from Vaccine

Questionnaire-based survey conducted by a group of Kochi-based doctors among 5,971 adults across the country to assess the community level experience of the pandemic

The U.S. Patent and Trademark Office has issued Patent No. 11,311,612 covering GeoVax Labs Inc's (NASDAQ:GOVX) modified vaccinia Ankara (MVA) vector expressing certain antigens from the malaria parasite. GeoVax's MVA-VLP malaria vaccine candidates incorporate antigens derived from multiple stages of the parasite's life cycle. They are designed to induce an immune response with durable…

Returning from a trip to the Bangladeshi highlands, the British actor and Unicef goodwill ambassador is calling on the UK government to do more to protect the world’s poorest against future crises

Corbevax has been approved for administration in children between ages of 5 and 12 and Covaxin has been approved for restricted use in emergency situations in children aged 6-12

"Do not let history repeat itself," advocates warn as low-income countries lack access to Pfizer treatment

Parents of children aged five and six are receiving letters offering jabs

Rhode Island state Sen. Sam Bell has introduced a bill that would require all unvaccinated residents of the state pay a $50-a-month fine. The fine would apply to everyone eligible for the vaccine. Bell's bill would also force unvaccinated Rhode Islanders to pay double their state income taxes.

Malaria is caused by a single-celled parasite of the genus Plasmodium. The parasite is transmitted to humans most commonly through mosquito bites. The malaria parasites enter the bloodstream and travel to the liver. When the parasites mature, they leave the liver and infect red blood cells.

Though experts’ understanding of COVID-19 has grown tremendously, the virus that causes it is an ever-changing story, challenging our ability to form policy that works from one season to the next.